Intratympanic steroid treatment of bell’s palsy in patients with comorbid disease: a preliminary report

Basit Öğe Kaydı
dc.authorid0000-0001-7914-2201en_US
dc.contributor.authorDemir, Deniz
dc.contributor.authorGenç, Sena
dc.contributor.authorGüven, Mehmet
dc.contributor.authorYılmaz, Mahmut Sinan
dc.contributor.authorKara, Ahmet
dc.contributor.authorErkorkmaz, Ünal
dc.contributor.authorDemir, Deniz
dc.date.accessioned2024-07-12T21:01:08Z
dc.date.available2024-07-12T21:01:08Z
dc.date.issued2020en_US
dc.departmentFakülteler, Tıp Fakültesien_US
dc.description.abstractOBJECTIVES: This study evaluated the efficacy of intratympanic steroid injection (ITSI)as initial treatment and therecovery speed for Bell’s palsy (BP)inpatients with diabetes mellitus (DM)and/or hypertension (HT). MATERIALS AND METHODS: In total,90 patients with comorbid diseases diagnosed with BP received either ITSI (study group, n=61) or systemic steroid treatment (SST) (control group, n=29).The facial nerve function was assessed using the House–Brackmann (HB) grading system for up to 6 months or until complete recovery from BP. To investigate a relationship with the complete recovery time from BP, hematologic and baseline characteristic parameters were analyzed. RESULTS: The complete recovery rate of the ITSI and SST groups was 47.5% and 44.8% at the 1st month, 70.5% and 89.7% at the 3rd month, and 96.7% and 100% at the 6th month of the study, respectively. Lymphocyte and neutrophil values were significantly associated with the complete recovery time from BP. No major adverse events from ITSI itself were noticed during the procedure and during the follow-up of the treatment. CONCLUSION: Both treatment types have no superiorities over each other in initial treatment for BP in patients with comorbid diseases. ITSI is effective and safe and may avoid the unwanted side effects associated with systemic steroids inthese patients.en_US
dc.identifier.citationDemir, D., Genç, S., Güven, M., Yılmaz, M.S., Kara, A. ve Erkorkmaz, Ü. (2020). Intratympanic steroid treatment of bell’s palsy in patients with comorbid disease: a preliminary report. The Journal of International Advanced Otology, European Academy of Otology and Neurotology and the Politzer Society. 16(1), s. 47-52.en_US
dc.identifier.endpage52en_US
dc.identifier.issn2148-3817
dc.identifier.issue1en_US
dc.identifier.startpage47en_US
dc.identifier.urihttps://advancedotology.org//en/intratympanic-steroid-treatment-of-bell-s-palsy-in-patients-with-comorbid-disease-a-preliminary-report-131501
dc.identifier.urihttps://hdl.handle.net/20.500.12415/3446
dc.identifier.volume16en_US
dc.institutionauthorDemir, Deniz
dc.language.isoenen_US
dc.publisherEuropean Academy of Otology and Neurotology and the Politzer Societyen_US
dc.relation.ispartofThe Journal of International Advanced Otologyen_US
dc.relation.isversionof10.5152/iao.2019.5415en_US
dc.relation.publicationcategoryUluslararası Editör Denetimli Dergide Makale - Başka Kurum Yazarıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmzKY03549
dc.subjectBell’s palsyen_US
dc.subjectsteroiden_US
dc.subjectintratympanic injectionen_US
dc.subjectdiabetes mellitusen_US
dc.subjecthypertensionen_US
dc.titleIntratympanic steroid treatment of bell’s palsy in patients with comorbid disease: a preliminary reporten_US
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Koleksiyon

Tıp Fakültesi Koleksiyonu